News
Chinese President XI Chastises Trudeau at G20 Summit
At the G20 summit, Chinese President Xi Jinping chastised Prime Minister Justin Trudeau for leaking details of a previous meeting, during which Trudeau expressed concern about Chinese interference in domestic affairs.
The two had a brief encounter at an event in Indonesia that was captured on video by news outlets. As the two spoke, a television camera was pointed directly at a Chinese interpreter.
“Everything we discussed has been leaked to the press; that is not appropriate,” Xi said through an interpreter to Trudeau. “And that’s not… how the conversation was conducted if you’re sincere,” Xi said, to which Trudeau interrupted and stepped toward Xi.
“We believe in free, open, and frank dialogue in Canada, and that is what we will continue to have,” Trudeau said. “We will continue to strive to collaborate constructively, but there will be points where we disagree.”
As Trudeau responded, Xi looked around.
“First, let us create the conditions,” Xi said through the interpreter.
Following their brief encounter, the two shook hands.
Trudeau met with Xi for the first time last Tuesday at the G-20 summit.
According to a senior Canadian government official, the two discussed Russia’s invasion of Ukraine and North Korea and climate change, and Trudeau expressed “our serious concerns about interference activities in Canada.”
The official requested anonymity because they were not authorized to speak publicly about the situation.
When asked about the confrontation later at a news conference, Trudeau said, “Not every conversation is always going to be easy, but it’s extremely important that we continue to stand up for what’s important for Canadians.”
Foreign Minister Mélanie Joly also discussed Chinese meddling with her Chinese counterpart at the G-20 meeting.
Joly noted last week that China is becoming a more disruptive global power and warned businesses against deepening their ties, citing “geopolitical risks.”
On Monday, police in Canada charged a Hydro-Québec employee with espionage for allegedly sending trade secrets to China. In addition, Beijing’s relations with Ottawa deteriorated after Canadian authorities arrested a top executive from the Chinese tech giant Huawei who had been charged with fraud in the United States.
China imprisoned two Canadians shortly after Canada arrested Meng Wanzhou, Huawei Technologies’ chief financial officer and the company’s founder’s daughter, on an extradition request from the United States. They were returned to Canada on the same day Meng returned to China after reaching an agreement with US authorities in her case last year.
Many countries referred to China’s actions as “hostage politics,” while China has described the charges against Huawei and Meng as a politically motivated attempt to stifle China’s economic and technological development.
Canada has barred wireless carriers from using Huawei equipment in its high-speed 5G networks, joining other allies in rejecting the company, which closely ties to the ruling Communist Party and its military wing, the People’s Liberation Army.
Former Canadian ambassador to China Guy Saint-Jacques believes Xi purposefully berated Trudeau in front of the camera.
“When you look at him, he has a red face and is moving his arms,” Saint-Jacques explained. “He appears agitated. He was upset with Trudeau for leaking the meeting’s details to the press. Interestingly, he said it wasn’t the way the meeting went.”
Saint-Jacques also observed that Trudeau interrupted Xi’s translation, which irritated Xi.
“The prime minister wanted to respond but knew he wouldn’t have time after Xi delivered his tirade,” Saint-Jacques said. “It’s clear that Xi has little respect for the Prime Minister.” It demonstrates how difficult it will be to reestablish limited dialogue with China.”
According to Saint-Jacques, Xi likely wanted to send a message to Trudeau that Canada would not dictate the terms of the relationship and that Trudeau should pay attention.
According to the former ambassador, Xi said, “You have to smarten up if you want to maintain any kind of relationship with us.”
“It’s unusual to see Xi Jinping engage in this type of public exercise to criticize someone,” Saint-Jacques added.
News
Katie Ledecky Hopes For Clean Races At Paris Olympics In The Aftermath Of The Chinese Doping Scandal
PARIS — Katie Ledecky is looking for clean Olympic races. On Wednesday, Hope had pretty much reached her limit.
The American swimmer hopes to add to her six gold medals as she competes in the 400, 800, and 1,500 meters at the Paris Games. Her program starts with the heavy 400 on Saturday, featuring Ariarne Titmus and Summer McIntosh.
Katie Ledecky | ESPN Image
Katie Ledecky Hopes For Clean Races At Paris Olympics In The Aftermath Of The Chinese Doping Scandal
The 27-year-old Katie is competing in her fourth Summer Olympics, but the first since a doping scandal involving almost two dozen Chinese swimmers who tested positive for a banned chemical before the Tokyo Games — yet were permitted to compete with no consequences. The controversy has raised serious worries regarding the effectiveness of anti-doping initiatives.
Katie Ledecky | Vogue Image
“I hope everyone here is going to be competing clean this week,” Ledecky claimed. “But what truly counts is, were they training cleanly? Hopefully this has been the case. Hopefully, there has been worldwide testing.”
The International Olympic Committee has expressed concern over the ongoing US investigation into possible doping by Chinese swimmers. While awarding the 2034 Winter Olympics to Salt Lake City on Wednesday, the IOC urged Utah officials to do whatever they could to stop the FBI investigation.
“I think everyone’s heard what the athletes think,” Katie added. “They seek transparency. They want more answers to the remaining questions. At this point, we are here to race. We are going to race whoever is in the lane next to us.
“We are not paid to conduct the tests, so we trust those who follow their regulations. That applies both today and in the future.
Katie Ledecky | ESPN Image
Katie Ledecky Hopes For Clean Races At Paris Olympics In The Aftermath Of The Chinese Doping Scandal
SOURCE | AP
As the summer holidays begin, London may experience an official heatwave with temperatures reaching up to 29 degrees Celsius.
The Met Office predicts a long period of sunny and dry weather for London after a soggy spring and summer.
After a cloudy day on Saturday, temperatures are expected to reach 27C on Sunday, with lots of sunlight.
On Monday and Tuesday, temperatures are forecast to peak at 29 degrees Celsius. Monday is forecast to offer more sunlight, while Tuesday may see some gloomy weather.
Temperatures are expected to remain in the high 20s next week, with lows of approximately 18C.
According to the Met Office, a heatwave is “an extended period of hot weather relative to the expected conditions of the area at that time of year, which may be accompanied by high humidity.”
In the United Kingdom, a heatwave is proclaimed when daily temperatures meet or surpass a certain level for at least three consecutive days.
In London, the heatwave threshold is 28 degrees Celsius.
The Met Office reported that the UK is experiencing hotter and wetter weather on average due to climate change.
The UK experienced its warmest May and April on record this year, despite damp and dismal conditions in many areas.
According to the Met Office’s State Of The UK Climate 2023 report published on Thursday, the UK experienced historic levels of extreme weather last year.
In the United Kingdom, 2023 was the second warmest year on record, bringing storms, flooding, strong heatwaves, and rising sea levels; only 2022 was warmer.
It was 0.8°C higher than the average from 1991 to 2020, and 1.66°C higher than the 1961 to 1990 average.
However, 2023 will be a “cool year” in comparison to 2100, based on the planet’s warming trajectory.
The government’s plan to adapt to the hazards presented by climate change is currently being challenged in the High Court by campaigners who allege the Tory administration’s July 2023 National Adaptation Programme (NAP) fails to adequately address 61 concerns.
Source: The Standard
(VOR News) – The European Union’s medical regulator has granted approval to Wegovy, a blockbuster weight loss treatment manufactured by Novo Nordisk, in order to expand its application to include the reduction of major heart events in overweight or obese adults.
In order to expand the scope of the medication’s applicability, this authorisation was granted. The purpose of obtaining this approval was to broaden the medicine’s application.
The Danish pharmaceutical company announced on Thursday that the European Medical Agency has formulated a “positive opinion” regarding the label’s expansion.
The agency made this determination after conducting a comprehensive examination of the results of a SELECT study that was subjected to rigorous monitoring. Other applications of the substance are facilitated by this conclusion.
The SELECT experiment, which was financed by Novo Nordisk and published in August 2023.
Wegovy and Ozempic contain semaglutide as the active ingredient.
Reduced the risk of major cardiovascular events by twenty percent when compared to a placebo. The researchers arrived at this conclusion. This realisation was the outcome of the researchers’ investigation.
The notion that the European Medicines Agency label for Wegovy should be amended is a significant step forward for patients who are coping with cardiovascular disease and obesity, according to Martin Holst Lange, executive vice president and director of development at Novo Nordisk.
The company’s statement, which was disclosed, indicated that the recommendation to update the label is a substantial advancement.
It is evident that Wegovy has the potential to save lives by reducing the likelihood of significant adverse cardiovascular events, as evidenced by the findings of the SELECT research. An additional benefit of participating in this exercise is that it helps individuals effectively manage their weight, which is a benefit in and of itself.
The company also stated that the label update incorporates data from the SELECT trial, which showed a 15% reduction in the risk of death from cardiovascular causes and a 19% reduction in the risk of death from any cause when compared to situations in which a placebo was used in conjunction with the product.
The SELECT trial was conducted in the United States, according to the company. Furthermore, the organisation disclosed that the SELECT investigation was conducted in the United States of America.
It is anticipated that the label amendment will be implemented within the next month, as per the statement issued by Novo Nordisk.
Wegovy has also been approved for use in the United States.
Similarly, the UK medical regulator has taken similar actions. The United Kingdom on Tuesday granted its clearance for the use of Wegovy to reduce the risk of significant cardiac difficulties or strokes in adults who are overweight or obese, such as heart attacks or strokes.
The Food and Drug Administration of the United States of America granted sanction for the medicine to be used in specific applications during the month of March.
This resulted in a rise in the number of distinct applications for the highly popular treatment, which coincides with the sector’s increasing level of competition.
On Thursday, Roche, a global pharmaceutical company with its headquarters in Switzerland, announced that its Wegovy competitor weight reduction tablets will be incorporated into a collection of pharmaceuticals designed to mitigate the adverse effects of obesity.
The pharmaceutical collection will encompass a diverse selection of weight loss medications.
The company’s Chief Executive Officer, Thomas Schinecker, conveyed his satisfaction with the exceptional early-stage trial results of the two potential weight-reduction pharmaceuticals that the company is currently developing. In addition, he asserted that these medications demonstrated the “best in disease potential.”
In making this assertion, Schinecker was alluding to the fact that the medications exhibited the “best in disease potential.” He also stated that they will be a part of a more comprehensive portfolio that is intended to set the Swiss company apart from its competitors in the growing obesity therapy market.
This adds insult to injury. This strategy will be implemented in order to distinguish the Swiss company from other businesses in the market.
SOURCE: CNBC
SEE ALSO:
A Strong U.S. GDP Report Boosts Oil, but Asia’s Economic Woes Limit Gains.
Surge in Covid Cases in Greece: Tourists Issued FLiRT Variant Warning
Business Owners Blame the Government’s Economic Incompetence for Rising Inflation.
-
World2 weeks agoFormer President Trump Survives Being Shot at Pennsylvania Rally
-
Tech4 weeks ago
Huawei Launches 5G-A Pioneers Program at MWC Shanghai 2024: Paving the Way for a Connected Future
-
Tech4 weeks ago
ChatGPT Answers Undiscovered Questions and Outperforms Students.
-
Sports4 weeks ago
NBA Draft: Kyle Filipowski Withdraws Unexpectedly From The First Round
-
News4 weeks ago
US Supreme Court Rejects Drug Deal that Protects the Sackler Family
-
Health4 weeks ago
US Health Agency Issues Dengue Virus Infection Warning
